← back to search

Matthias Miederer

DKFZ-ZMBH Alliance · DE
🔎 Find collaborators in Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, and Prostate Cancer Treatment and Research.
h-index
30
citations
4,870
works
176
NIH funding
primary concept
Medicine
email

Recent publications

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
European Urology 2025cited by 23position: middledoi
Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
Journal of Nuclear Medicine 2025cited by 18position: middledoi
PET imaging utilization and trends in Germany: a comprehensive survey
European Journal of Nuclear Medicine and Molecular Imaging 2025cited by 6position: middledoi
“Precision on Two Wheels”─Structural Refinement of <sup>64</sup> Cu- and <sup>68</sup> Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application
Journal of Medicinal Chemistry 2025cited by 3position: middledoi
Combined [18F]Fluorodeoxyglucose PET and [123I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias—the cross-sectional diagnostic test accuracy study FAMIAN
EBioMedicine 2025cited by 3position: middledoi
Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE
Cancer Imaging 2025cited by 3position: lastdoi
Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial
International Journal of Radiation Oncology*Biology*Physics 2025cited by 2position: middledoi
Alpha-Emitting Radionuclides: Current Status and Future Perspectives
Pharmaceuticals 2024cited by 55position: firstdoi
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium
Journal of Experimental & Clinical Cancer Research 2024cited by 8position: middledoi
Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
Cancer Imaging 2024cited by 3position: lastdoi
Genetic Code Expansion for Site-Specific Labeling of Antibodies with Radioisotopes
ACS Chemical Biology 2023cited by 12position: lastdoi
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort
Cancer Imaging 2023cited by 5position: lastdoi
Late-Onset Prosthetic Endocarditis with Paraaortic Abscess Caused by Cutibacterium acnes
Infectious Disease Reports 2023cited by 3position: middledoi
Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by<sup>90</sup>Y Radioembolization: A Multicenter Retrospective Study
Journal of Nuclear Medicine 2022cited by 15position: middledoi
Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis
Cancers 2022cited by 12position: middledoi
DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases
Frontiers in Nuclear Medicine 2022cited by 8position: middledoi
Value of PET imaging for radiation therapy
Strahlentherapie und Onkologie 2021cited by 24position: middledoi
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial
Radiotherapy and Oncology 2021cited by 17position: middledoi
549 An RNA-lipoplex (RNA-LPX) vaccine demonstrates strong immunogenicity and promising clinical activity in a Phase I trial in cutaneous melanoma patients with no evidence of disease at trial inclusion
Regular and Young Investigator Award Abstracts 2021cited by 10position: middledoi
Alpha emitting nuclides in nuclear medicine theranostics
Nuklearmedizin - NuclearMedicine 2021cited by 7position: firstdoi
Value of PET imaging for radiation therapy
Nuklearmedizin - NuclearMedicine 2021cited by 5position: middledoi
Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA
EJNMMI Research 2021cited by 5position: firstdoi
The Impact of Radiotherapy Protocol Adherence on the Treatment Outcome in Patients With Locally Advanced NSCLC Treated With Concurrent Chemoradiation: Results From the Radiotherapy Quality Assurance of the International Randomized PET-Plan Trial
International Journal of Radiation Oncology*Biology*Physics 2021cited by 1position: middledoi
Correction to: Value of PET imaging for radiation therapy
Strahlentherapie und Onkologie 2021cited by 1position: middledoi
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Nature 2020cited by 998position: middledoi
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
The Lancet Oncology 2020cited by 173position: middledoi
Dual-Time Point [68Ga]Ga-PSMA-11 PET/CT Hybrid Imaging for Staging and Restaging of Prostate Cancer
Cancers 2020cited by 36position: middledoi
PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
Cancers 2020cited by 25position: middledoi
A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma.
Journal of Clinical Oncology 2020cited by 21position: middledoi
Targeting of Immune Cells with Trimannosylated Liposomes
Advanced Therapeutics 2020cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mathias Schreckenberger · Johannes Gutenberg University Mainz15 papers (2013–2025)Stefanie Pektor · Johannes Gutenberg University Mainz14 papers (2015–2023)Christian Fottner · Johannes Gutenberg University Mainz11 papers (2013–2025)Matthias M. Weber · Johannes Gutenberg University Mainz11 papers (2013–2025)Nicole Bausbacher · Johannes Gutenberg University Mainz10 papers (2012–2023)Ursula Nestle · Heidelberg University8 papers (2015–2025)Frank Rösch · Johannes Gutenberg University Mainz8 papers (2015–2022)Thomas J. Musholt · Johannes Gutenberg University Mainz7 papers (2013–2025)Tanja Schimek‐Jasch · University of Freiburg7 papers (2015–2025)Eleni Gkika · Deutschen Konsortium für Translationale Krebsforschung6 papers (2020–2025)Anca‐Ligia Grosu · German Marine Research Consortium6 papers (2015–2025)Marco Tosch · Helios Universitätsklinikum Wuppertal6 papers (2015–2023)S. Eschmann · BARMER GEK6 papers (2015–2023)Michael Mix · University Medical Center Freiburg5 papers (2015–2021)Harald Binder · SMART Reading5 papers (2020–2025)G. Höll · Helios Kliniken5 papers (2015–2021)Sonja Adebahr · Heidelberg University5 papers (2020–2025)Hans Christian Rischke · University of Freiburg5 papers (2015–2021)Stephanie Kremp · Saarland University4 papers (2020–2021)Marcus Stockinger · Johannes Gutenberg University Mainz4 papers (2020–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine →